GHK-Cu Tripeptide — Stability Data Summary
GHK-Cu (Glycyl-L-Histidyl-L-Lysine copper(II) complex) is among the most studied tripeptides in dermatological research. Below is a stability data summary across four sequential production lots.
Compound Identity
Sequence: H-Gly-His-Lys-OH · Cu(II). Molecular formula C14H22CuN6O4. Calculated MW 401.91. Observed [M+H]+ by ESI-MS: 402.1 ± 0.5.
Lot Purity (HPLC, 220 nm)
| Lot | Released | Purity (T0) | Purity (90 d) |
|---|---|---|---|
| 2025-09-002 | 2025-09-15 | 99.4% | 99.3% |
| 2025-10-004 | 2025-10-08 | 99.2% | 99.1% |
| 2025-11-001 | 2025-11-04 | 99.5% | 99.4% |
| 2025-12-003 | 2025-12-17 | 99.3% | 99.2% |
Storage Conditions
Lyophilized vials stored at −20 °C, desiccated, sealed. 90-day reassay performed on retain samples held under identical conditions.
Conclusion
GHK-Cu shows excellent storage stability under cold-chain conditions, with <0.2% loss over 90 days. Reconstituted solution should be used within 21 days when stored at 2–8 °C.
RUO. Internal lot summary; not a clinical specification.